Last reviewed · How we verify
Xenon gas inhalation
At a glance
| Generic name | Xenon gas inhalation |
|---|---|
| Also known as | Inhalation of xenon gas |
| Sponsor | General Biophysics LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease (PHASE2)
- Xenon Therapy for Children With Autism Spectrum Disorder (PHASE1, PHASE2)
- Xenon MRI and Progressive ILD (PHASE2)
- Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults (PHASE1, PHASE2)
- Gas Exchange MRI to Visualize Regional Therapy Response in Interstitial Lung Disease (PHASE1, PHASE2)
- Genentech Xenon MRI Idiopathic Pulmonary Fibrosis (PHASE2)
- Hyperpolarized 129-Xenon MRI in Fibrosing Interstitial Lung Disease
- Hyperpolarized Xenon-129 Magnetic Resonance Imaging and Spectroscopy of Brown Fat: Healthy Adult Volunteer Pilot Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Xenon gas inhalation CI brief — competitive landscape report
- Xenon gas inhalation updates RSS · CI watch RSS
- General Biophysics LLC portfolio CI